申请人:Protech Inc.
公开号:EP3988090A1
公开(公告)日:2022-04-27
Provided are a composition for promoting ER-phagy, a composition for maintaining ER homeostasis or reducing ER stress, and a pharmaceutical composition for preventing and/or treating ER-stress-related diseases, which comprise a p62 ligand compound as an active ingredient.
本发明提供了一种用于促进ER吞噬的组合物、一种用于维持ER平衡或减少ER应激的组合物,以及一种用于预防和/或治疗ER应激相关疾病的药物组合物,其中包含一种p62配体化合物作为活性成分。